Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early transition to sulfonylurea therapy in infant with DEND syndrome due to F132L ABCC8 mutation.

Acta diabetologica - 1 Sept 2022

Tikhonovich Yulia, Petryaykina Elena, Zubkova Natalya, Garyaeva Irina, Tiulpakov Anatoly

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Hypoglycemic Agents
Share to Infant
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Sulfonylurea Compounds

Share to Sulfonylurea Receptors

Source

Identifiers

PMID: 35648253
DOI: 10.1007/s00592-022-01904-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early transition to sulfonylurea therapy in infant with DEND syndrome due to F132L ABCC8 mutation.PMID 35648253Read ↗

Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.Semantic proximity Read ↗

Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation.Semantic proximity Read ↗

Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.Semantic proximity Read ↗

Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.Semantic proximity Read ↗

A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up.Semantic proximity Read ↗

DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.Semantic proximity Read ↗

Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11Semantic proximity Read ↗

Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation.Semantic proximity Read ↗

Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.Semantic proximity Read ↗

Neonatal diabetes mellitus due to a novel ABCC8 gene mutation mimicking an organic acidemia.Semantic proximity Read ↗

First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.Semantic proximity Read ↗

ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.